Abstract: QUESTIONS UNDER STUDY: We sought to identify reasons for late human immunodeficiency virus (HIV) testing or late presentation for care. METHODS: A structured chart review was performed to obtain data on test-and health-seeking behaviour of patients presenting late with CD4 cell counts below 350 cells/µl or with acquired immunodeficiency syndrome (AIDS), at the Zurich centre of the Swiss HIV Cohort Study between January 2009 and December 2011. Logistic regression analyses were used to compare demographic characteristics of persons presenting late with not late presenters. RESULTS: Of 281 patients, 45% presented late, 48% were chronically HIV-infected non-late presenters, and an additional 7% fulfilled the <350 CD4 cells/µl criterion for late presentation but a chart review revealed that lymphopenia was caused by acute HIV infection. Among the late presenters, 60% were first tested HIV positive in a private practice. More than half of the tests (60%) were suggested by a physician, only 7% following a specific risk situation. The majority (88%) of patients entered medical care within 1 month of testing HIV positive. Risk factors for late presentation were older age (odds ratio [OR] for 50 vs <30 years: 3.16, p = 0.017), Asian versus Caucasian ethnicity (OR 3.5, p = 0.021). Compared with men who have sex with men (MSM) without stable partnership, MSM in a stable partnership appeared less likely to present late (OR 0.50, p = 0.034), whereas heterosexual men in a stable partnership had a 2.72-fold increased odds to present late (p = 0.049). CONCLUSIONS: The frequency of late testing could be reduced by promoting awareness, particularly among older individuals and heterosexual men in stable partnerships. 
Introduction
Untreated infection with the human immunodeficiency virus (HIV) progressively destroys the immune system leading to opportunistic illnesses and death. Since potent combination antiretroviral therapy (cART) has been introduced, morbidity and mortality of HIV-infected people has drastically improved [1] [2] [3] . However, a substantial proportion of individuals are not aware of their HIV infection or do not present for care and treatment until the disease is advanced [4] . Late initiation of cART results in less favourable outcomes [5] [6] [7] and is associated with increased medical costs [8] . Furthermore, untreated people may contribute to the spread of HIV for many years. In Europe, 33% to 42% and 49% to 54% of individuals were reported not to be diagnosed with HIV until having CD4 cell count values below 200 cells/µl [9] [10] [11] [12] and 350 cells/µl [4, 13, 14] , respectively, and up to 30% present with an acquired immunodeficiency syndrome (AIDS) defining illness [15] . Unfortunately, different definitions for late presentation complicate direct comparisons of the study findings [16] . A recent initiative resulted in a European consensus definition for late presentation of HIV-infected persons: Individuals presenting for care with a CD4 cell count below 350 cells/µl or with an AIDS-defining illness regardless of CD4 cell count should be classified as late presenters [16] . Late presentation for care comprises two entities which are believed to be quite different from each other in terms of risk factors and interventions: (i.) late HIV testing, which reflects patients who are unaware of their HIV infection, and (ii.) delayed presentation for care, including individuals who are aware of their HIV infection but do not seek care right away.
The aim of this study was to apply this new consensus definition to individuals entering care in a large HIV outpatient clinic and to identify reasons for late HIV testing or presentation for care through a detailed chart review. The structured questionnaire developed during this study could then serve for further prospective studies.
Methods

Patients and data collection
We selected patients from the University Hospital Zurich, the largest centre of the Swiss HIV Cohort Study (SHCS). The SHCS is a nationwide, multicentre cohort with continuous enrollment of HIV-infected individuals and semiannual study visits [17] . The responsible ethics committees of each study centre approved this cohort study and written informed consent was obtained from all individuals included. The retrospective chart review was approved by the Kantonale Ethikkomission Zürich (KEK-ZH-Nr. 2011-0455). For this study we included all individuals who were enrolled in the SHCS from January 2009 to December 2011 at the HIV outpatient clinic of the Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich with available CD4 cell count at enrollment. Persons with CD4 cell counts below 350 cells/µl or with an AIDS-defining illness were considered to be potential late presenters. The other individuals served as a comparison group. During the data collection it became clear that the group of potential late presenters included a considerable number of persons with acute HIV infection whose CD4 cell counts were below 350 cells/µl at the time of enrollment. To ascertain that no individuals with acute HIV infection were classified as late presenter or not late presenter we matched data with the database of the Zurich Primary HIV Infection Study (ZPHI; ClinicalTrials.gov identifier, NCT00537966). This study includes all patients of the HIV outpatient clinic of the Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich with acute or recent HIV-1 infection, defined as (i.) acute retroviral syndrome and negative or indeterminate Westernblot in the presence of a positive p24 antigen and/or detectable plasma HIV-1 ribonucleic acid (RNA), (ii.) documented seroconversion with or without symptoms within 90 days, or (iii.) possible acute seroconversion syndrome (ARS), positive Westernblot and detectable HIV-RNA, and a negative HIV-gp120 avidity, respectively detuned assay. We thus analysed three groups of individuals: patients with an acute or recent HIV infection, chronically infected not late presenters, and late presenters. Demographic characteristics and laboratory results were obtained from the SHCS database. The development of the questionnaire was partially based on the questionnaire of the HIV Denmark initiative (courtesy of Prof. Jens D. Lundgren, Copenhagen HIV Programme) which has been extended and adapted as a result of a pilot chart review of late presenting patients and feedback from the community. For a report on this project see http://www.hiv-danmark.dk/fileadmin/user_upload/hivdanmark/pdf/Late_presenters-FINAL.pdf. As the questionnaire also had to be suitable for further studies with prospective patient interviews, we included items which were unlikely to be adequately documented in the clinical records, such as symptoms and structural factors at the time of the first HIV test, fear and emotional response to HIV infection, stigma and individual risk appraisal. Information about the following items was included for further analysis: (i.) setting in which the first positive HIV test was performed, (ii.) reasons for the performance of the test, (iii.) HIV-related symptoms before first HIV test, (iv.) number of physicians seen because of the symptoms before first positive HIV test, and (v.) duration between first positive test and entering into medical care.
Ambiguity scores
Diagnostic procedures for newly diagnosed HIV-1 infections include a genotypic resistance test to detect potentially transmitted drug resistance mutations, which have to be considered when choosing the initial antiretroviral treatment. As recently described by researchers from the SHCS (www.shcs.ch) and the Zurich Primary HIV Infection Study (ZPHI; ClinicalTrials.gov identifier, NCT00537966), the results from these resistance tests can also be used to estimate the duration of the HIV infection by determining the fraction of ambiguous nucleotides [18] . In bulk sequencing, ambiguous nucleotide calls arise when different viral strains do not permit a precise determination of the nucleotide at a specific position. The fraction of ambiguous nucleotides thus reflects the polymorphism of the HIV population within a patient and is an indirect measure of the age of infection. To evaluate the suitability of ambiguity scores for distinguishing the three patient groups, we applied this method for all individuals who had results from enrollment resistance tests available from the SHCS resistance database.
Statistical analyses
We used EpiData V3.1 (http://www.epidata.dk, The EpiData Association, Odense Denmark) for data collection and Stata/SE 13.1 (StataCorp, College Station, Texas, USA) for analyses. Comparisons across groups for categorical variables were done with Chi-square tests, or Fisher's exact test if an expected cell count was less than five. Continuous variables were analysed with Wilcoxon ranksum tests (two groups) or Kruskal-Wallis tests (three groups). Factors associated with late presentation compared with the combined groups of not late presentation and acute HIV infection were further analysed with univariable and multivariable logistic regression. Results of the logistic regression were reported as odds ratios (ORs) with 95% confidence intervals (CIs). We considered sex, transmission categories (men who have sex with men [MSM] and heterosexual intercourse), living in a stable partnership, ethnicity, age (<30, 30-39, 40-49, 50+ years) and educational level in the models. Transmission categories of injection drug use (IDU) and of other risks were excluded from the logistic regression because of small numbers. We allowed for interactions between sex, transmission category and type of partnership by creating a combined variable with six levels: (i.) MSM without stable partner, (ii.) male heterosexual without stable partner, (iii.) female heterosexual without stable partner, (iv.) MSM with
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Swiss Med Wkly. 2014;144:w13961 stable partner, (v.) male heterosexual with stable partner, and (vi.) female heterosexual with stable partner. Patients were defined as living in stable partnerships if they answered affirmatively on the question of whether they had had a stable partnership for the preceding 6 months in an interviewer-administered questionnaire at a regular SHCS follow-up visit. A p-value <0.05 was considered statistically significant.
Results
Patient characteristics
From 01 January 2009 to 07 December 2011, 318 patients were enrolled in the Zurich centre of the SHCS and had a CD4 cell count available. The chart review revealed that 37 individuals did not qualify as late presenters, mostly because referral letters showed that they had been in care for a longer period elsewhere prior to enrollment in the SHCS. These people were excluded from the analysis since we had no information about their initial CD4 cell counts. Of the remaining 281 patients, 146 (52%) had a CD4 cell count below 350 cells/µl and/or an AIDS-defining disease at re- (17) 97 (78) 28 (22) 21 (100) (22) 9 (7) 21 (15) 4 (3) 3 (2) 1 (1) 98 (73) 3 (2) 49 (39) 25 (20) 24 (19) 4 (3) 2 (1) 2 (1) 67 (54) 5 (4) 
83 (29) 38 (13) 45 (16) 8 (3) 5 (2) 3 (1) 182 (65) The frequency of late presentation was low among individuals with a university degree or a completed apprenticeship (36% and 38%, respectively) and high among individuals who didn't finish school or had only completed mandatory school (62% and 56%, respectively). However figure 1 . A total of 79 patients (63%) consulted a physician because of these symptoms. Before an HIV test was performed, a median of two different physicians (IQR 1-3) were seen because of the symptoms. However, once HIV was diagnosed, the majority (88%) of individuals entered medical care within 1 month, and only 4.8% waited for 1 year or more. increased odds (95% CI 1.23-8.17, p = 0.017), and Asian people, as compared with Caucasians, had 3.5-fold increased odds of presenting late (95% CI 1.21-10.14, p = 0.021). Compared with MSM without stable partnership, MSM in a stable partnership were significantly less likely to present late (OR 0.50, 95% CI 0.27-0.95, p = 0.034), whereas heterosexual men in a stable partnership had 2.72-fold increased odds to present late (95% CI 1.004-7.37, p = 0.049).
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Ambiguous HIV-1 nucleotides to estimate the duration of the HIV infection
Discussion
A total of 45% of the 281 newly enrolled HIV-infected individuals in our clinic between 01 January 2009 and 07 December 2011 were late presenters according to the European consensus definition, with a CD4 cell count threshold of below 350 cells/µl or an AIDS-defining illness [16] . This is considerably less than in the reports from Germany, England and New Zealand with 49.5%, 49% and 50%, respectively [13, 14, 19] . COHERE, a large European collaborative study involving over 80,000 patients from 35 countries recently even found a prevalence of 52% late presenters in 2010/2011 [4] . Without a careful chart review, we would have included 21 persons who presented with acute HIV infection, resulting in 146 of 281 persons (52%). Although the consensus definition advises repeating CD4 cell count determinations to exclude transient lymphopenia, such confirmation is not mandatory and may explain some of the variations between reports with data sources from different settings.
With routinely performed genotypic resistance tests we demonstrated that the fraction of ambiguous nucleotides [18] successfully discriminated the three groups in our study and that it is a valid tool for further epidemiological analyses. The analysis of risk factors for late presentation revealed that the HIV transmission categories, sex, and partnership status, are not independent. We created a combined variable of the above characteristics, which allowed us to dissect differential effects. For example, MSM in a stable partnership are much less likely to present late than heterosexual men in a stable partnership. This finding is in concordance with a French study where, among non-migrants, longstanding heterosexual couples had the highest risk for late presentation [10] . Similarly, the association of late presentation with older age has been described in several other studies [10, 12, 13, 20, 21] . Furthermore, a higher risk for late presentation in immigrants and ethnic groups other than Caucasians has been shown previously [9, 11, 12, 20] . Whereas Africans and Hispanics showed no difference in late presentation compared to Caucasians in our study, Asians were at significantly higher risk for late presentation.
The chart review revealed that the majority of late presenting patients had symptoms and were diagnosed in private practices. Only 7.2% of individuals specifically asked for an HIV test because of the symptoms and a further 7.2% because they were aware of a risk situation. The fact that in our study almost 90% entered medical care within 1 month after diagnosis shows that access to healthcare is excellent in Switzerland. A study on delayed entry into HIV medic- 
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Figure 1
Prevalence of symptoms prior to the HIV test among the 125 late presenters. Error bars represent the 95% exact binomial confidence intervals. HIV = human immunodeficiency virus 
